Occurrence of Nephrogenic Systemic Fibrosis with Group II Gadolinium-Based Contrast Agent in a Pediatric Oncology Patient with AKI

被引：0
|
作者：
Hanna, Christian [1 ]
Scheuermann, Amanda [2 ]
Hopp, Amanda M. [2 ]
Young, Kara [2 ]
Dillon, John J. [1 ]
Van Why, Scott K. [2 ]
机构：
[1] Mayo Clin Minnesota, Rochester, MN USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO2018
引用
收藏
页码：620 / 620
页数：1
相关论文
共 50 条
  • [41] Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent A Systematic Review and Meta-analysis
    Woolen, Sean A.
    Shankar, Prasad R.
    Gagnier, Joel J.
    MacEachern, Mark P.
    Singer, Lisa
    Davenport, Matthew S.
    JAMA INTERNAL MEDICINE, 2020, 180 (02) : 223 - 230
  • [42] Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent
    Clorius, S.
    Technau, K.
    Watter, T.
    Schwertfeger, E.
    Fischer, K.-G.
    Walz, G.
    Gerke, P.
    CLINICAL NEPHROLOGY, 2007, 68 (04) : 249 - 252
  • [43] Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents
    Smorodinsky, Emmanuil
    Ansdell, David S.
    Foster, Zeke W.
    Mazhar, Sameer M.
    Cruite, Irene
    Wolfson, Tanya
    Sugay, Sebastian B.
    Iussich, Gabriella
    Shiehmorteza, Masoud
    Kono, Yuko
    Kuo, Alexander
    Sirlin, Claude B.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2015, 41 (05) : 1259 - 1267
  • [44] Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
    Pieringer, Herwig
    Schumacher, Sabine
    Schmekal, Bernhard
    Gitter, Thomas
    Biesenbach, Georg
    CLINICAL KIDNEY JOURNAL, 2008, 1 (03): : 193 - 194
  • [45] Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis: Why Did It Happen and What Have We Learned?
    Weinreb, Jeffrey C.
    Abu-Alfa, Ali K.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1236 - 1239
  • [46] Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents
    Hanno Hoppe
    Sara Spagnuolo
    Johannes M. Froehlich
    Helga Nievergelt
    Hans-Peter Dinkel
    Silvia Gretener
    Harriet C. Thoeny
    European Radiology, 2010, 20 : 595 - 603
  • [47] Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation
    Edward, M.
    Quinn, J. A.
    Burden, A. D.
    Newton, B. B.
    Jardine, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (04) : 930 - 930
  • [48] Effect of Different Classes of Gadolinium-based Contrast Agents on Control and Nephrogenic Systemic Fibrosis-derived Fibroblast Proliferation
    Edward, Michael
    Quinn, Jean A.
    Burden, A. David
    Newton, Ben B.
    Jardine, Alan G.
    RADIOLOGY, 2010, 256 (03) : 735 - 743
  • [49] Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis
    Yantasee, Wassana
    Fryxell, Glen E.
    Porter, George A.
    Pattamakomsan, Kanda
    Sukwarotwat, Vichaya
    Chouyyok, Wilaiwan
    Koonsiripaiboon, View
    Xu, Jide
    Raymond, Kenneth N.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (01) : 1 - 8
  • [50] Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training
    Alabousi, Mostafa
    Davenport, Matthew S.
    RADIOLOGY, 2021, 300 (02) : 279 - 284
12345